Targeting RSK2 reverses endocrine resistance in ER-positive breast cancer via inhibiting the c-Myc–ERBB4 signaling pathway

Infrared Physics & Technology · Elsevier

Аннотация

Publication date: November 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 11 Author(s): Ting Jiang, Shilong Jiang, Yueying Cheng, Xiaohui Yu, Zonglin Chen, Hang Li, Shijun Cao, Zhongyuan Xiang, Ruigang Zhao, Wenjun Yi, Jinming Yang, Yan Cheng

Читать у издателя →

Похожие статьи